CorMedix Inc (NASDAQ: CRMD) stock closed at $5.28 on 4/10/24 after a major increase of 11.2%. Moreover, this advance was accompanied by exceptionally high trading volume at 311% of normal. The stock has been weak relative to the market over the last nine months but has risen 29.4% during the last week.
Current PriceTarget Research Rating
Reflecting future returns on capital that are forecasted to be in line with the cost of capital, CRMD is expected to continue to be Value Creation neutral.
CorMedix has a current Value Trend Rating of F (Lowest Rating). With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing inconsistent signals. CorMedix has a neutral Power Rating of 40 but a very low Appreciation Score of 3, triggering the Lowest Value Trend Rating.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of F. This review will be completed in the next several days.
Be the first to comment